Patent family, assignee, and citation context
Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.
Complete US patent database with forward citations, assignee normalization, inventor networks, CPC/IPC classification, government interest statements, and publication numbers normalized to FDA Orange Book format.
Request context access
Ask us to provision this analytical context into your BigQuery or Snowflake workspace.
Request AccessRelated context
Overview
Portfolio and BD teams use this context to model protection runway, challenge pressure, and loss-of-exclusivity timing.
Complete US patent database with forward citations, assignee normalization, inventor networks, CPC/IPC classification, government interest statements, and publication numbers normalized to FDA Orange Book format.
Build patent cliff and loss-of-exclusivity timelines using normalized patent, exclusivity, and approval identifiers.
Compare FDA-listed patents with USPTO metadata, assignee networks, and forward citation context.
Separate substance, product, and method-of-use protection when modeling generic or biosimilar entry.
Join IP records to revenue, labels, clinical stage, and target biology through the drug identity spine.
Source authority
USPTO PatentsView
Freshness
Last refreshed 2026-07-01
Quarterly
Coverage
8M+ patents
2 delivery tables